NM_003659.4:c.1856-16G>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003659.4(AGPS):​c.1856-16G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.102 in 1,612,246 control chromosomes in the GnomAD database, including 10,782 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.092 ( 920 hom., cov: 32)
Exomes 𝑓: 0.10 ( 9862 hom. )

Consequence

AGPS
NM_003659.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0780

Publications

16 publications found
Variant links:
Genes affected
AGPS (HGNC:327): (alkylglycerone phosphate synthase) This gene is a member of the FAD-binding oxidoreductase/transferase type 4 family. It encodes a protein that catalyzes the second step of ether lipid biosynthesis in which acyl-dihydroxyacetonephosphate (DHAP) is converted to alkyl-DHAP by the addition of a long chain alcohol and the removal of a long-chain acid anion. The protein is localized to the inner aspect of the peroxisomal membrane and requires FAD as a cofactor. Mutations in this gene have been associated with rhizomelic chondrodysplasia punctata, type 3 and Zellweger syndrome. [provided by RefSeq, Jul 2008]
AGPS Gene-Disease associations (from GenCC):
  • alkylglycerone-phosphate synthase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • rhizomelic chondrodysplasia punctata type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 2-177538058-G-T is Benign according to our data. Variant chr2-177538058-G-T is described in ClinVar as Benign. ClinVar VariationId is 259117.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.343 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGPSNM_003659.4 linkc.1856-16G>T intron_variant Intron 19 of 19 ENST00000264167.11 NP_003650.1 O00116
AGPSXM_011512041.3 linkc.1586-16G>T intron_variant Intron 19 of 19 XP_011510343.1 B7Z3Q4
AGPSXM_047446104.1 linkc.1586-16G>T intron_variant Intron 19 of 19 XP_047302060.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGPSENST00000264167.11 linkc.1856-16G>T intron_variant Intron 19 of 19 1 NM_003659.4 ENSP00000264167.4 O00116

Frequencies

GnomAD3 genomes
AF:
0.0916
AC:
13926
AN:
151972
Hom.:
917
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0565
Gnomad AMI
AF:
0.170
Gnomad AMR
AF:
0.0724
Gnomad ASJ
AF:
0.123
Gnomad EAS
AF:
0.356
Gnomad SAS
AF:
0.161
Gnomad FIN
AF:
0.0671
Gnomad MID
AF:
0.130
Gnomad NFE
AF:
0.0931
Gnomad OTH
AF:
0.0976
GnomAD2 exomes
AF:
0.114
AC:
28563
AN:
251092
AF XY:
0.117
show subpopulations
Gnomad AFR exome
AF:
0.0528
Gnomad AMR exome
AF:
0.0664
Gnomad ASJ exome
AF:
0.133
Gnomad EAS exome
AF:
0.349
Gnomad FIN exome
AF:
0.0768
Gnomad NFE exome
AF:
0.0922
Gnomad OTH exome
AF:
0.112
GnomAD4 exome
AF:
0.103
AC:
149805
AN:
1460156
Hom.:
9862
Cov.:
32
AF XY:
0.104
AC XY:
75859
AN XY:
726430
show subpopulations
African (AFR)
AF:
0.0591
AC:
1973
AN:
33402
American (AMR)
AF:
0.0690
AC:
3081
AN:
44650
Ashkenazi Jewish (ASJ)
AF:
0.129
AC:
3363
AN:
26070
East Asian (EAS)
AF:
0.373
AC:
14786
AN:
39658
South Asian (SAS)
AF:
0.158
AC:
13617
AN:
86206
European-Finnish (FIN)
AF:
0.0795
AC:
4245
AN:
53400
Middle Eastern (MID)
AF:
0.143
AC:
821
AN:
5758
European-Non Finnish (NFE)
AF:
0.0909
AC:
100971
AN:
1110722
Other (OTH)
AF:
0.115
AC:
6948
AN:
60290
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
6691
13381
20072
26762
33453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3818
7636
11454
15272
19090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0915
AC:
13921
AN:
152090
Hom.:
920
Cov.:
32
AF XY:
0.0930
AC XY:
6915
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.0564
AC:
2342
AN:
41528
American (AMR)
AF:
0.0725
AC:
1106
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.123
AC:
426
AN:
3470
East Asian (EAS)
AF:
0.357
AC:
1839
AN:
5158
South Asian (SAS)
AF:
0.161
AC:
776
AN:
4818
European-Finnish (FIN)
AF:
0.0671
AC:
711
AN:
10602
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.0931
AC:
6327
AN:
67934
Other (OTH)
AF:
0.0975
AC:
206
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
643
1286
1930
2573
3216
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0920
Hom.:
1192
Bravo
AF:
0.0909
Asia WGS
AF:
0.231
AC:
800
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 15, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 05, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Rhizomelic chondrodysplasia punctata type 3 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
6.5
DANN
Benign
0.74
PhyloP100
0.078
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3213945; hg19: chr2-178402786; COSMIC: COSV51562123; API